Irit Nachtigall, Sven Hohenstein, Andreas Bollmann, Marzia Bonsignore, Daniela Husser, Ralf Kuhlen, Andreas Meier Hellmann
{"title":"Thrombembolic Events in Hospitalized COVID-19 Patients: What is the Role of the Sex?","authors":"Irit Nachtigall, Sven Hohenstein, Andreas Bollmann, Marzia Bonsignore, Daniela Husser, Ralf Kuhlen, Andreas Meier Hellmann","doi":"10.1055/a-1585-9536","DOIUrl":null,"url":null,"abstract":"Over a year ago, the WHO declared COVID-19 a pandemic; from then on, all hopeswere on the development of vaccines. So far, 4 vaccines have been approved in Europe. On March 11, 2021, the European Medicines Agency (EMA) reported 30 cases of thromboembolic events (TE) that were observed within 2 weeks after vaccinations with the AstraZeneca vaccine Vaxzevria, mostly being cerebral venous sinus thromboses in women younger than 60 years. Ca. 5 million people had received Vaxzevria in the EEA by then. Several European countries stopped their vaccinations with Vaxzevria temporarily. COVID-19 infections increase the risk of developing TE. It has not yet been reported whether women develop more TE under Covid-19 than men. The aim of the present study was to determine the frequency, sex distribution and risk factors of TE among SARS-CoV-2 positive patients.","PeriodicalId":22238,"journal":{"name":"TH Open: Companion Journal to Thrombosis and Haemostasis","volume":"5 3","pages":"e411-e414"},"PeriodicalIF":0.0000,"publicationDate":"2021-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8455179/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"TH Open: Companion Journal to Thrombosis and Haemostasis","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1055/a-1585-9536","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/7/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Over a year ago, the WHO declared COVID-19 a pandemic; from then on, all hopeswere on the development of vaccines. So far, 4 vaccines have been approved in Europe. On March 11, 2021, the European Medicines Agency (EMA) reported 30 cases of thromboembolic events (TE) that were observed within 2 weeks after vaccinations with the AstraZeneca vaccine Vaxzevria, mostly being cerebral venous sinus thromboses in women younger than 60 years. Ca. 5 million people had received Vaxzevria in the EEA by then. Several European countries stopped their vaccinations with Vaxzevria temporarily. COVID-19 infections increase the risk of developing TE. It has not yet been reported whether women develop more TE under Covid-19 than men. The aim of the present study was to determine the frequency, sex distribution and risk factors of TE among SARS-CoV-2 positive patients.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
